GlassScriptPhysician profile
Vanessa Antoine
NPI 1477940864
$510.98
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.04 · 2020: $50.52 · 2021: $203 · 2022: $169.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $201.50 | 2019-2022 | |
| Exeltis, USA INC. | $116.43 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.69 | 2021 | |
| Hologic Sales and Service, LLC | $40.21 | 2021-2022 | |
| Agile Therapeutics, INC. | $26.53 | 2021 | |
| Mayne Pharma Commercial LLC | $24.38 | 2021 | |
| Amgen INC. | $17.25 | 2019 | |
| Astellas Pharma US INC | $15.73 | 2019 | |
| Therapeuticsmd, INC. | $14.91 | 2022 | |
| Coopersurgical, INC. | $13.35 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Antoine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.